NASDAQ:NNNN | News | Anbio Biotechnology

NNNN News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-05-19Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.
2026-04-27Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.
2026-02-17Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.
2026-01-26Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.
2025-12-30Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.
2025-11-13Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.
2025-02-21Foreign issuer reportSEC filingAnbio Biotechnology filed Form 6-KAnbio Biotechnology filed Form 6-K.